Alzamend Neuro (ALZN) Current Assets (2020 - 2026)

Alzamend Neuro has disclosed Current Assets across 7 years of filings, most recently posting $1.8 million for Q2 2026.

• In Q2 2026, Current Assets fell 57.76% year-over-year to $1.8 million; the TTM figure through Apr 2026 stood at $1.8 million (down 57.76% YoY), while the FY2026 annual figure was $1.8 million, down 57.76% from the prior year.
• Current Assets came in at $1.8 million for Q2 2026 at Alzamend Neuro, down from $3.7 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $14.4 million in Q2 2022 to a low of $455242.0 in Q2 2024.
• Average Current Assets over 5 years is $5.5 million, with a median of $4.4 million recorded in 2025.
• Year-over-year, Current Assets sank 92.95% in 2024 and surged 817.62% in 2025.
• Over 5 years, Current Assets stood at $10.3 million in 2022, then slumped by 92.43% to $781881.0 in 2023, then surged by 509.65% to $4.8 million in 2024, then dropped by 0.95% to $4.7 million in 2025, then sank by 62.63% to $1.8 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $1.8 million in Q2 2026, $3.7 million in Q1 2026, and $4.7 million in Q4 2025.